Collagen Cross-Linking (CXL) for Keratoconus
Keratoconus is a progressive disease of the cornea. With collagen cross-linking (CXL), you can halt the progression of keratoconus by strengthening your cornea. This ground-breaking procedure has helped tens of thousands of people around the world. NVISION is proud to offer the only FDA approved cross-linking treatment for keratoconus and it is covered by many major insurance plans.
-
Keratoconus
The disease causes progressive weakening and thinning of the cornea, which causes it to bulge into a cone shape. It is typically not correctable with glasses, requiring specialty contact lenses, or in severe cases if left untreated, a corneal transplant.
-
How does cross-linking work?
If you have keratoconus, your cornea has too few cross-links—or support beams—allowing your cornea to bulge outward into a cone shape.
The cross-linking procedure adds cross-links to your cornea. Once it has been distorted, the cornea cannot regain shape, but this procedure stabilizes and strengthens your cornea, which stops the thinning process and limits further vision loss. -
Why choose NVISION to treat your keratoconus?
NVISION is one of the leaders in keratoconus care and surgery. Most importantly, our surgeons are keratoconus surgery pioneers and they thoroughly analyze your unique condition to develop a personalized treatment approach.
-
Is cross-linking right for me?
Early treatment for keratoconus is necessary to prevent it’s progression. While the patients that benefit the most from crosslinking are in their teens or twenties, any patient that demonstrates active disease with progressive thinning can benefit. CXL is a treatment to consider if you are in one of the following categories:
- You have been newly diagnosed with keratoconus. The earlier you have the treatment, the earlier you have the potential of stopping your disease from progressing.
- You have been living with keratoconus—even if you are getting good vision with contacts. Your disease may very well be progressing despite good vision or comfortable contact lens wear. Any progression is irreversible, and CXL is the only procedure that can stop the progression of the disease.
NVISION® Eye Centers can be found throughout California, Nevada, Oregon, and in Toronto, Canada. Each center is a little bit different—but what they have in common are talented NVISION® surgeons, caring staff, and a commitment to a gold standard for patient care.
